Divalent metal ion additives in perovskites for x-ray detectors
By incorporating divalent metal ions into perovskite precursor solutions to reduce vacancies, the energy resolution and charge collection efficiency of perovskite detectors are enhanced, addressing the performance gap with CZT detectors.
Patent Information
- Application Number
- PCT/US2025/039122
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-16
- Filing Date
- 2025-07-24
- Publication Date
- 2026-11-19
AI Technical Summary
Perovskite single crystal detectors suffer from poor energy resolution due to defects such as A-site vacancies and interstitials, which cause charge trapping states, hindering their commercialization and performance compared to other semiconductor detector technologies like CZT.
Introduce divalent metal ion additives, such as Ba²⁺, Cd²⁺, Sr²⁺, or Ca²⁺, into the perovskite precursor solution to replace a small percentage of lead ions, reducing lead and X-site vacancies, thereby enhancing mobility-lifetime products and charge collection efficiency.
The addition of divalent metal ions improves the energy resolution and charge collection efficiency of perovskite detectors, bringing them closer to the performance levels of commercial CZT detectors.
Smart Images

Figure IMGF000030_0001 
Figure IMGF000031_0001_TABLE 
Figure 00000049_0000
Abstract
Description
Attorney Docket No. 035052 / 634770DIVALENT METAL ION ADDITIVES IN PEROVSKITES FOR X-RAY DETECTORSCROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U. S. Provisional Application No. 63 / 683,895, filed August 16, 2024.STATEMENT OF GOVERNMENT SUPPORT
[0002] This invention was made with government support under Grant No. HDTRA1-20-2-0002 awarded by Department of Defense. The government has certain rights in the invention.FIELD
[0003] The presently disclosed subject matter relates generally to divalent metal ion additives in perovskites for detectors, such as X-ray detectors and gamma-ray detectors with enhanced charge collection efficiency.BACKGROUND
[0004] Perovskite materials have been demonstrated or envisioned to provide advantages in a wide array of applications including spectroscopic detectors and charge integration detectors. Certain perovskite materials, such as single crystal perovskites materials with an ordered structure, provide for enhanced detection efficiency compared to polycrystalline films. However, various classes of perovskite single crystals detectors suffer from poor energy resolution compared to other types of semiconductor detector technologies, such as cadmium zinc telluride (CZT) detectors.
[0005] A significant challenge for the commercialization of perovskite single crystal detectors is the presence of defects including A-site vacancies and interstitials, which cause charge trapping states in the perovskite single crystals. Ongoing research to reduce defects, such as through surface passivation techniques, has not adequately addressed the problem of reducing A-site vacancies and interstitials to provide improved energy resolution.BRIEF SUMMARY
[0006] In one aspect, the presently disclosed subject matter is directed to a perovskite precursor solution comprising:Attorney Docket No. 035052 / 634770i. a perovskite material of formula APbXs, wherein, A comprises one or more cations having an ionic radius less than about 260 pm, and X is selected from the group consisting of Cl’, Br’, I’, and F’, and combinations thereof;ii. an additive material of formula MZ2 or MY, wherein, M is a divalent metal ion; Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, and acetate, and combinations thereof, and Y is selected from the group consisting of O2’ and CCh2'; andiii. one or more solvents.
[0007] In another aspect, the subject matter described herein is directed to a perovskite single crystal of formula APbX.3, wherein A comprises one or more cations having an ionic radius less than about 260 pm, and X is selected from the group consisting of CF, Br’, I’, and F’, and combinations thereof. In various embodiments, said single crystal comprises a plurality of Pb vacancies occupied by a dopant, wherein said dopant comprises a divalent metal ion, and is present in said perovskite single crystal in an amount of about 1 to about 9 mol % relative to Pb in said perovskite single crystal.
[0008] In another aspect, the subject matter described herein is directed to a semiconductor device comprising said perovskite single crystal, a metal layer deposited on a first surface of said perovskite single crystal, and a carbon layer deposited on a second surface of said perovskite single crystal, wherein said second surface is approximately parallel to said first surface.
[0009] In another aspect, the subject matter described herein is directed to a method of producing a perovskite single crystal. In various embodiments, the method comprises preparing a perovskite precursor solution comprising a perovskite material of formula APbXs and an additive of material of formula MZ2 or MY in one or more solvents, wherein the perovskite material of formula APbX j is formed from AX and PbX2, wherein A comprises one or more cations having an ionic radius less than about 260 pm, X is selected from the group consisting of Cl’, Br, I’, and F’, and combinations thereof, M is a divalent metal ion, Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, and acetate, and combinations thereof, and Y is selected from the group consisting of O2’ and CCh2’. In various embodiments, the method also comprises heating said perovskite precursor solution.
[0010] These and other aspects are described herein.BRIEF DESCRIPTION OF FIGURESAttorney Docket No. 035052 / 634770
[0011] Figure 1A shows a plot of energy resolution for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution.
[0012] Figure IB shows a plot of charge collection efficiency for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution.
[0013] Figure 1C shows a plot of Photopeak / Compton peak height (P / C) ratio for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution.
[0014] Figure ID shows a plot of dark current density for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution.
[0015] Figure IE shows a plot of a137Cs spectrum of an undoped FAPbBr3 single crystal device.
[0016] Figure IF shows a plot of a137Cs spectrum of a FAPbBr3 single crystal device prepared with 2 mol% of Ba2+added to its precursor solution.
[0017] Figure 2A shows plots of precursor solubility curves for FAPbBr₃ precursor solutions prepared with varying amounts of Ba2+.
[0018] Figure 2B shows plots of unit cell volume and full-width at half maximum (FWHM) of a (001) XRD peak of FAPbBr3 single crystals prepared with varying amounts of Ba2+added to their respective precursor solution.
[0019] Figure 2C shows plots of dark current density for FAPbBr3 single crystal devices prepared with varying amounts of Ba2+added to their respective precursor solution.
[0020] Figures 2D through 2H show plots of137Cs spectra of FABaxPb1-xBr3 single crystal devices prepared with varying amounts of Ba2+added to their respective precursor solution.
[0021] Figure 3 A shows an optical image, under daylight, of FAPbBr3 single crystals prepared with varying amounts of Cl⁻ added to their respective precursor solution.
[0022] Figure 3B shows a plot of energy resolution for FAPbBr3 single crystals prepared with varying amounts of Cl⁻ added to their respective precursor solution.
[0023] Figure 3C shows a plot of a137Cs spectrum of a FAPbBr3 single crystal prepared withAttorney Docket No. 035052 / 634770
[0024] Figure 4A shows a schematic diagram of a perovskite single crystal device with a guard-ring based electrode structure.
[0025] Figure 4B shows a plot of dark current density under varying bias voltages for FAPbBr3 single crystal devices prepared with and without a guard ring.
[0026] Figure 4C shows a plot of a137Cs spectrum of a FAPbBr3 single crystal device prepared with a guard ring and 2 mol% of Ba2+added to its precursor solution.
[0027] Figure 5 A shows plots of energy resolution (ER) and dark current density for FAPbBr3 single crystal devices prepared with varying amounts of Ba2+stoichiometrically or non-stoichiometrically added to their respective precursor solution.
[0028] Figure 5B shows a plot of a137Cs spectrum of a FAPbBr3 single crystal device prepared without a guard ring and 2 mol% of BaBr2 non-stoichiometrically added to its precursor solution.
[0029] Figure 6A shows a plot of response current of a FAPbBr3 single crystal device under varying X-ray dose rates.
[0030] Figure 6B shows a plot of current density of a control device under varying X-ray dose rates.
[0031] Figure 6C shows a plot of response current, under varying X-ray dose rates, of a FAPbBr3 single crystal device prepared with 2 mol% of Ba2+added to its precursor solution.
[0032] Figure 6D shows a plot of current density of a control device under varying X-ray dose rates.
[0033] Figure 7A shows a schematic diagram (top) of a perovskite solar cell and a plot (bottom) of electron mobility-lifetime product fitting, according to the Hecht equation, of channel numbers of241Am 59.5 kiloelectronvolt (keV) photopeaks, under varying bias voltages, for a FAPbBr3 single crystal device prepared with 2 mol% of Ba2+added to its precursor solution.
[0034] Figure 7B shows a schematic diagram (top) of a perovskite solar cell and a plot (bottom) of hole mobility-lifetime product fitting, according to the Hecht equation, for channel numbers of241Am 59.5 keV photopeaks, under varying bias voltages, for a FAPbBr3 single crystal device prepared with 2 mol% of Ba2+added to its precursor solution.
[0035] Figure 8A shows a plot of energy resolution, as a function of testing time under high bias, for a FAPbBr3 single crystal device prepared with 2 mol% of Ba2+added to its precursor solution.Attorney Docket No. 035052 / 634770
[0036] Figure 8B shows a plot of energy resolution (ER) as a function of temperature for a CZT device, an undoped FAPbBr3 single crystal device, and a FAPbBr3 single crystal device prepared with 2 mol% of Ba2+added to its precursor solution (referred to herein an optimized FAPbBr3 single crystal device).
[0037] Figure 8C shows a plot of a137Cs spectrum, collected before an ice bath, for a FAPbBr3 single crystals prepared with 2 mol% of Ba2+added to its precursor solution.
[0038] Figure 8D shows a plot of a137Cs spectrum, collected after a 3 hour ice bath, for a FAPbBr3 single crystals prepared with 2 mol% of Ba2+added to its precursor solution.DETAILED DESCRIPTION
[0039] The subject matter described herein is directed to metal ion additives in perovskites that, provide improved spectroscopic X-ray or gamma-ray detectors, and more sensitive non- spectroscopic detectors. Adding the metal ion additives to perovskite single crystals or polycrystalline films, or replacing a portion of lead ions (e.g., a few percent of lead ions) in perovskite single crystals or polycrystalline films with the metal ion additives, may enhance mobility-lifetime products of charges in the perovskite single crystals or polycrystalline films and thus enhance charge collection efficiency of the resulting detectors.I. Overview
[0040] Advancements in direct X-ray and gamma-ray semiconductor detectors are pivotal for numerous applications including medical imaging, industry material inspection, scientific research, and national security.1Some existing radiation detectors include silicon (Si), amorphous selenium (a-Se), mercury(II) iodide (HgI2), cadmium zinc telluride (CZT), high-purity germanium (HPGe), and thallium(I) bromide (TIBr), among other examples. However, such radiation detectors are associated with various limitations that prevent them from broader application. For instance, Si and a-Se are not suitable for high energy spectroscopic detectors due to their relatively weak stopping power; TIBr and HgI2are susceptible to polarization effect and stability issues;2,3HPGe requires cryogenic cooling to suppress high dark current due to its small bandgap of 0.66 eV4; and CZT is expensive (-2,000-3,000$ per cm3)5. Room-temperature X-ray and gamma-ray spectroscopic detectors have stringent criteria on semiconductor materials used in the detectors, including relatively large atomic number for high stopping power, relatively large mobility-lifetime (μτ) product for efficient charge collection, relatively large bulk resistivity (>109Ohm-Attorney Docket No. 035052 / 634770centimeters (Qcm)) for low noise, relatively large bandgap for room -temperate operation, and relatively low trap density for avoiding charge traps. Thus, the search for semiconductor materials capable of surpassing existing commercial technologies remains a pressing challenge.
[0041] Perovskites, such as metal halide perovskites (MHP) are arising as a new generation semiconductor for X-ray detection, including spectroscopic detectors and charge integration detectors. MHPs have high stopping powers to ionizing radiation due to heavy atoms such as Pb, Bi, I, and Br, high mobility-lifetime products6, a unique defect tolerance7, and relatively large bandgaps. Additionally, MHPs are relatively difficult to dope8and are formed via cost-effective fabrication techniques5. Single crystal perovskites, with an ordered structure and thus low defect density, outperform polycrystalline films in many aspects due to more efficient charge transport and collection, less charge trapping, and enhanced detection efficiency. Spectroscopic X-ray and gamma-ray detectors have been broadly demonstrated with some MHP compositions. However, despite MHPs having a larger bandgap, the energy resolution of some MHP single crystal spectroscopic detectors has yet to reach the parity of market-dominating, room-temperature semiconductor detector technologies based on CZT.
[0042] Multiple types of defects exist in crystalline materials. Non-negligible defects present in perovskite single crystals cause their performance to deviate from predicted ideal device performance. Taking MAPbBr3 as example, experimental results and computations show that defects present in MAPbBr3 include Br vacancies (X-site defects), Pb interstitials (B-site defects), and MA vacancies and interstitials (A-site defects). In some cases, the MA vacancies and interstitials are the predominate cause of charge trapping states in MAPbBr3 single crystals.9Some research efforts have been directed to managing A-site and X-site related defects at both the crystal surface level and at the crystal interior level. For instances, a surface passivation strategy has been developed in which ammonium bromide is used to passivate deep-traps on FAPbBrs surfaces, including FA vacancies, uncoordinated Pb, and Pb-Pb dimers caused by bromide loss. However, this surface passivation strategy may not impact bulk defects.10Another strategy includes introducing excess MABr and large cations of methylformamidinium (MFA) that come from, for example, the reaction between MA and FA11in the synthesis of MAPbBr3 crystals. While this strategy has been shown to reduce defect densities for both MA vacancy and interstitial defects in MAPbBr3 crystals, the resulting device performance (e.g., an energy resolution of 3.9% for the 662 keV photopeak from a137Cs gamma-ray source) of the MAPbBr3 crystals was substantiallyAttorney Docket No. 035052 / 634770inferior to leading commercial products, such as those based on CZT9. Despite lead vacancy concentrations being known to reach as high as 9(6) x 1016cm-3in MAPbI3 crystals, few research efforts focus on lead vacancies compared to other possible sources of deep traps in lead halide perovskites.12
[0043] As shown herein, divalent metal ion additives may be introduced into metal halide perovskites during synthesis to reduce lead vacancies. For example, the present disclosure provides for a method in which divalent metal ions (M2+) are added to, or replace a small percentage of lead ions in, an APbX3 perovskite precursor solution, in which A can be MA+, FA+, or Cs+, among other cations and X can be Cl⁻, Br⁻, or F⁻, among other anions. This modification improves the mobility-lifetime products of charges and increases the bulk resistivity of crystals, which enhances charge collection efficiency and reduces device noise. Although the methods described herein are described in the context of solution growth, it is to be understood that the principles of the methods are applicable to crystals grown by other methods, such as via the Bridgeman process. In other words, the divalent metal ions can be incorporated in crystals grown by other methods, such as via the Bridgeman process.
[0044] In various embodiments, a single dopant is used to reduce lead (Pb) vacancies and X-site vacancies. That is, in various embodiments, the divalent metal ions can be incorporated into perovskite crystals using a single dopant, which reduces Pb vacancies and X-site vacancies. For example, X-site vacancies are known to be one of the dominating defect types in the surface of perovskite single crystals. Thus, in various embodiments, a single dopant (e g., MBr2) may be added to reduce surface X-site vacancies, in addition to Pb-site vacancies. For example, non-stoichiometric amounts of the single dopant may be added to perovskite precursor solutions to reduce bulk Pb vacancies and surface Br vacancies in the resulting single crystals. The use of a single dopant may reduce device fabrication costs and complexity. In some instances, if the radius of one or more ions incorporated into the crystalline lattice exceeds a threshold, the one or more ions may cause lattice mismatch, which can lead to one or more defects. For example, if one or more cations incorporated into the A-sites of the crystalline lattice are too large, the one or more cations may cause Pb vacancies due to lattice mismatch. Accordingly, to further reduce Pb vacancies (and thereby further improve the mobility -lifetime products of charges and increases the bulk resistivity of crystals), A in the APbX3 perovskite precursor solution can be one or moreAttorney Docket No. 035052 / 634770cations having an ionic radius less than a threshold. In some instances, the threshold is about 260 pm.
[0045] The presently disclosed subject matter will now be described more fully hereinafter. However, many modifications and other embodiments of the presently disclosed subject matter set forth herein will come to mind to one skilled in the art to which the presently disclosed subject matter pertains having the benefit of the teachings presented in the foregoing descriptions. Therefore, it is to be understood that the presently disclosed subject matter is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. In other words, the subject matter described herein covers all alternatives, modifications, and equivalents. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in this field. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In the event that one or more of the incorporated literature, patents, and similar materials differs from or contradicts this application, including but not limited to defined terms, term usage, described techniques, or the like, this application controls.II. Definitions
[0046] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the present application and relevant art and should not be interpreted in an idealized or overly formal sense unless expressly so defined herein. The terminology used in the description of the invention herein is for the purpose of describing particular aspects only and is not intended to be limiting of the invention. In case of a conflict in terminology, the present specification is controlling.
[0047] As used herein, the term “and / or” refers to and encompasses any and all possible combinations of one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative (“or”).
[0048] The term “or” refers to any one member of a particular list.Attorney Docket No. 035052 / 634770
[0049] Unless otherwise apparent from the context, the term “about” when referring to a measurable value such as an amount of a compound or agent of the current subject matter, dose, time, temperature, and the like, is meant to encompass variations of ±20%, ±10%, ±5%, ±1%, ±0.5%, or even ±0.1% of the specified amount.
[0050] The terms “approximately,” “about,” “essentially,” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, in some embodiments, as the context may dictate, the terms “approximately”, “about”, and “substantially” may refer to an amount that is within less than or equal to 10% of the stated amount. The term “generally” as used herein represents a value, amount, or characteristic that predominantly includes or tends toward a particular value, amount, or characteristic.
[0051] As used herein, conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and / or steps. Thus, such conditional language is not generally intended to imply that features, elements and / or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and / or steps are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list.
[0052] The singular forms of the articles “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a protein” or “at least one protein” can include a plurality of proteins, including mixtures thereof.
[0053] As used herein, “PCE” refers to power conversion efficiency. The terms “power conversion efficiency,” “PCE,” “photovoltaic efficiency”, and “solar cell efficiency,” may be used interchangeably and refer to the ratio of energy output from the photovoltaic device to the energy input to the photovoltaic device. The energy output is in the form of electrical energy and energyAttorney Docket No. 035052 / 634770input is in the form of electromagnetic radiation (e.g., sunlight). Unless otherwise indicated, the photovoltaic efficiency refers to terrestrial photovoltaic efficiency, corresponding to AMI.5 conditions, where AM is Air Mass. PCE may be measured by one or more techniques conventionally known to one of ordinary skill in the art.
[0054] As used herein, “photoactive device” refers to a device capable of and configured to convert electromagnetic radiation (e.g., gamma-ray, X-ray, infrared, ultraviolet, and / or visible light) to electrical energy and / or converting electrical energy to electromagnetic radiation. A photoactive device may be configured to both convert light to electrical energy (e.g., as a solar cell) and convert electrical energy to light (e.g., via electroluminescence), for example depending on the direction of electrical current in the device (e.g., depending on whether electrical power is withdrawn from or supplied to the device). Exemplary photoactive devices include, but are not limited to, a photovoltaic cell (also referred to as a solar cell), a photodiode, and a light emitting diode (LED). In various embodiments, a photoactive device can also refer to a device configured to change its optical, physical, and / or electrical properties with change in its exposure to electromagnetic radiation and / or a device configured to change its optical properties in response to a change in input of electrical energy. Exemplary photoactive devices can also include, but are not limited to, a photoresistor, phototransistor, photomultiplier, photoelectric cell, and an electrochromic cell.
[0055] As used herein, “halide,” refers to a halogen atom bearing a negative charge. Nonlimiting examples of halides include fluoride, chloride, bromide, iodide, and astatide.
[0056] As used herein, “pseudohalide,” refers to a polyatomic analogue of a halide. Nonlimiting examples of pseudohalides include cyanide, cyaphide, isocyanide, hydroxide hydrosulfide, hydroselenide, hydrotelluride, cyanate, isocyanate, fulminate, thiocyanate, isothiocyanate, selenocyante, tellurocyanate, azide, nitroxide, nitrogen dioxide, tetracarbonylcobaltate, trinitromethanide, tricyanomethanide, l,2,3,4-thiatriazol-5-thiolate, and auride.
[0057] As used herein, “a second surface being approximately parallel to a first surface,” and the like, refers to a first surface and a second surface that are not perpendicular to each other (e.g., do not intersect at a 90° angle). In some examples, such as examples in which a second surface is approximately parallel to a first surface, the first surface and / or the second surface may be uneven and may not be exactly parallel (e.g., equidistant) in all regions.Attorney Docket No. 035052 / 634770
[0058] As used herein, “a vacancy,” and the like, refers to the absence of an atom or molecule from a point that it would normally occupy in a crystal. For example, “a Pb vacancy,” and the like, refers to the absence of a Pb atom from a point that it would normally occupy in a crystal.
[0059] As used herein, “interstitial,” and the like, refers to an atom or molecule occupying a potion within a crystal, which is not typically occupied by the atom or molecule, and which is between other atoms or molecules in the crystal.
[0060] As used herein, “ionic radius” refers to the radius of a monatomic ion in an ionic crystal structure.III. Perovskite Precursor Solutions
[0061] In one aspect, the subject matter described herein is directed to a perovskite precursor solution, comprising:i. a perovskite material of formula APbXs,wherein,A comprises one or more cations having an ionic radius less than about 260 pm; andX is selected from the group consisting of Cl’, Br, I’, and F’, and combinations thereof;ii. an additive material of formula MZ2 or MY,wherein,M is a divalent metal ion;Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, acetate, and combinations thereof;Y is selected from the group consisting of O2’ and CCh2’; andiii. one or more solvents.
[0062] In various embodiments of the perovskite precursor solution, the divalent metal ion has an ionic radius of about 45 pm to about 175 pm. In various embodiments of the perovskite precursor solution, the divalent metal ion has an ionic radius of about 95 pm to about 145 pm, about 60 pm to about 120 pm, about 45 pm to about 75 pm, about 75 pm to about 150 pm, about 85 pm to about 135 pm, about 90 pm to about 110 pm, about 100 pm to about 155 pm, about 85 pm to about 165 pm, about 50 pm to about 100 pm, about 105 pm to about 150 pm, about 125 pm to about 135 pm, about 115 pm to about 150 pm, about 145 pm to about 165 pm, or about 136 pmAttorney Docket No. 035052 / 634770to about 175 pm. In various embodiments of the perovskite precursor solution, the divalent metal ion has an ionic radius of about 109 pm, 110 pm, 111 pm, 112 pm, 113 pm, 114 pm, 115 pm, 116 pm, 117 pm, 118 pm, 119 pm, 120 pm, 121 pm, 122 pm, 123 pm, 124 pm, 125 pm, 126 pm, 127 pm, 128 pm, 129 pm, 130 pm, 131 pm, 132 pm, 133 pm, 134 pm, 135 pm, 136 pm, 137 pm, 138 pm, 139 pm, 140 pm, 141 pm, 142 pm, 143 pm, 144 pm, 145 pm, 146 pm, 147 pm, 148 pm, or149 pm.
[0063] In various embodiments of the perovskite precursor solution, the divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+. In various embodiments of the perovskite precursor solution, the divalent metal ion is selected from the group consisting of Cd2+, Yb2+, Ba2+, and Sm2+. In various embodiments, the divalent metal ion is Ba2+.
[0064] In various embodiments of the perovskite precursor solution, the one or more halides include at least one of Cl', Br', I', or F', and the one or more pseudohalides include at least one of CN', SCN', Ns', or (OH)'. In various embodiments of the perovskite precursor solution, Z is Br'. In various embodiments, the additive is BaBr2.
[0065] In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius less than about 255 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius of 250 pm, 251 pm, 252 pm, 253 pm, or 254 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius less than about 220 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius of 215 pm, 216 pm, 217 pm, 218 pm, or 219 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius less than about 190 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius of 165 pm, 166 pm, 167 pm, 167 pm, 169 pm, 170 pm, 171 pm, 172 pm, 173 pm, 174 pm, 175 pm, 176 pm, 178 pm, 179 pm, 180 pm, 181 pm, 182 pm, 183 pm, 184 pm, 185 pm, 186 pm, 188 pm, or 189 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius less than about 160 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius of150 pm, 151 pm, 152 pm, 153 pm, 154 pm, or 155 pm. In various embodiments of the perovskite precursor solution, the one or more cations have an ionic radius less than about 120 pm. In variousAttorney Docket No. 035052 / 634770embodiments of the perovskite precursor solution, the one or more cations have an ionic radius of 115 pm, 116 pm, 117 pm, 118 pm, or 119 pm.
[0066] In various embodiments of the perovskite precursor solution, A is selected from the group consisting of methyl ammonium (MA), formamidinium (FA), Na+, K+, Rb+, and Cs+, and combinations thereof. In various embodiments of the perovskite precursor solution, A is selected from the group consisting of MA, FA, and Cs+, and combinations thereof. Unless indicated otherwise, when A is or comprises “methylammonium (MA),” it refers to (CH.3NH3+). Unless indicated otherwise, “formamidinium,” as used herein, refers to [R2NCHN 2]+where each R is hydrogen, (H2N=CH— NH2).
[0067] In various embodiments of the perovskite precursor solution, X is a combination of Cl' and Br. In various embodiments of the perovskite precursor solution, the perovskite material comprises a perovskite composition of formula APbBrs.yCly In various embodiments of the perovskite precursor solution, y is from 0 to about 0.75, from 0 to about 0.50, from 0 to about 0.25, from 0 to about 0.1, from 0 to about 0.05. In various embodiments of the perovskite precursor solution, y is 0.01, 0.02, 0.03, 0.04, or 0.05.
[0068] In various embodiments of the perovskite precursor solution, the divalent metal ion is present in the perovskite precursor solution in a first ratio of n moles relative to A in the perovskite precursor solution. In various embodiments of the perovskite precursor solution, n is from about 0.01 to about 0.08, from about 0.01 to about 0.04, or from about 0.01 to about 0.02.
[0069] In various embodiments of the perovskite precursor solution, Pb is present in the perovskite precursor solution in a second ratio of k moles relative to A in the perovskite precursor solution. In various embodiments of the perovskite precursor solution, k is from about 1 to about 0.92.
[0070] In various embodiments of the perovskite precursor solution, the one of more solvents selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, dimethylformamide, dimethyl sulfoxide, acetonitrile, propionitrile, acetone, ethylacetate, methylene chloride, chloroform, methanol, ethanol, propanol, butanol, isopropanol, ethylene glycol, diethyl ether, glyme, diglyme, propylene carbonate, N-methyl-2-pyrrolidinone, y-Butyrolactone (gamma-butyrolactone), tetrahydrofuran, benzene, toluene, decalin, hexamethylphosphoramide, pyridine, alkylpyridine, pyrrolidine, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, water, carbon disulfide, supercritical carbon dioxide, carbonAttorney Docket No. 035052 / 634770tetrachloride, 2 -Methoxy ethanol, 1 -methyl -2-pyrrolidinone, and sulfuryl chloride fluoride. In various embodiments of the perovskite precursor solution, the one of more solvents selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, dimethyl sulfoxide, dimethylformamide, y-butyrolactone, 2-methoxy ethanol, 1 -methyl -2-pyrrolidinone, toluene, propylene carbonate, and acetonitrile.
[0071] In various embodiments, the one or more solvents comprise a mixed-solvent system. In various embodiments of the perovskite precursor solution, the mixed-solvent system comprises dimethylformamide and y-butyrolactone. In various embodiments, the one or more solvents comprise a mixed-solvent system. In various embodiments of the perovskite precursor solution, the mixed-solvent system comprises dimethylformamide:y-butyrolactone in a ratio of approximately 1: 1 volume per volume. In other words, in various embodiments of the perovskite precursor solution, the mixed solvent system comprises dimethylformamide and y-butyrolactone in equal amounts volume per volume. In various embodiments of the perovskite precursor solution, the mixed-solvent system comprises dimethylformamide and propylene carbonate. In various embodiments of the perovskite precursor solution, the mixed-solvent system comprises dimethylformamide:propylene carbonate in a ratio of approximately 2:1 volume per volume. In other words, in various embodiments of the perovskite precursor solution, the mixed solvent system comprises twice the amount of dimethylformamide as propylene carbonate volume per volume.
[0072] It will be understood by a person of ordinary skill in the art that the perovskite material and the additive material are dissolved in the one or more solvents and therefore mixed together. Additionally, while Z is described as being selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, and acetate, and combinations thereof, it will be understood by a person of ordinary skill in the art that Z may include one or more other types of anions (e.g., any inorganic or organic anion) that are soluble in the one or more solvents.IV. Perovskite Single Crystals
[0073] In one aspect, the subject matter described herein is directed to a perovskite single crystal of formula APbX3, wherein: A comprises one or more cations having an ionic radius less than about 260 pm, X is selected from the group consisting of Cl", Br, I", and F", and combinations thereof, the single crystal comprising a plurality of Pb vacancies occupied by a dopant, whereinAttorney Docket No. 035052 / 634770the dopant comprises a divalent metal ion, and is present in the perovskite single crystal in an amount of about 1 to about 9 mol % relative to Pb in the perovskite single crystal.
[0074] In various embodiments of the perovskite single crystal, the dopant predominately resides in the plurality of Pb vacancies that occur below a surface of the perovskite single crystal. In other words, in various embodiments of the perovskite single crystal, the dopant predominately resides in Pb vacancies that occur within the bulk of the perovskite single crystal, which occurs below a surface layer of the perovskite single crystal. As described herein, the surface refers to a portion of the perovskite single crystal in which the lattice of the perovskite single crystal ends. Accordingly, as described herein, the surface layer includes atoms of the perovskite single crystal that occur at an interface of the perovskite single crystal, such as an interface between the perovskite single crystal and another material (e.g., bismuth or carbon) or between the perovskite single crystal and air. In various embodiments, the surface layer includes a single layer of atoms that occur at the interface of the perovskite single crystal. In various embodiments, a thickness of the surface layer is based on a respective radius of one or more atoms in the single layer of atoms. In various embodiments, the dopant predominately resides in Pb vacancies that occur below the surface layer. In various embodiments, the dopant primarily resides in Pb vacancies that occur at a depth from the interface of the perovskite single crystal in which the depth is based on the respective radius of the one or more atoms.
[0075] In various embodiments of the perovskite single crystal, the divalent metal ion has an ionic radius of about 45 pm to about 175 pm. In various embodiments of the perovskite single crystal, the divalent metal ion has an ionic radius of about 95 pm to about 145 pm, about 60 pm to about 120 pm, about 45 pm to about 75 pm, about 75 pm to about 150 pm, about 85 pm to about 135 pm, about 90 pm to about 110 pm, about 100 pm to about 155 pm, about 85 pm to about 165 pm, about 50 pm to about 100 pm, about 105 pm to about 150 pm, about 125 pm to about 135 pm, about 115 pm to about 150 pm, about 145 pm to about 165 pm, or about 136 pm to about 175 pm. In various embodiments of the perovskite single crystal, the divalent metal ion has an ionic radius of about 109 pm, 110 pm, 111 pm, 112 pm, 113 pm, 114 pm, 115 pm, 116 pm, 117 pm, 118 pm,119 pm, 120 pm, 121 pm, 122 pm, 123 pm, 124 pm, 125 pm, 126 pm, 127 pm, 128 pm, 129 pm,130 pm, 131 pm, 132 pm, 133 pm, 134 pm, 135 pm, 136 pm, 137 pm, 138 pm, 139 pm, 140 pm,141 pm, 142 pm, 143 pm, 144 pm, 145 pm, 146 pm, 147 pm, 148 pm, or 149 pm.Attorney Docket No. 035052 / 634770
[0076] In various embodiments of the perovskite single crystal, the divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+. In various embodiments of the perovskite single crystal, the divalent metal ion is selected from the group consisting of Cd2+, Yb2+, Ba2+, and Sm2+. In various embodiments of the perovskite single crystal, the divalent metal ion is Ba2+.
[0077] In various embodiments of the perovskite single crystal, the one or more halides include at least one of Cl', Br', I', or F', and the one or more pseudohalides include at least one of CN', SCN', Ns', or (OH)'. In various embodiments of the perovskite single crystal, Z is Br'. In various embodiments of the perovskite single crystal, the additive is selected from the group consisting of BaBr2, BaCh, Bah, BaF2, Ba(CN)2, Ba(SCN)2, Ba(O3)2, Ba(OH)2, Ba(NO3)2, Ba(C2H3O2)2, CdBr2, CdCl2, Cdl2, CdF2, Cd(CN)2, Cd(SCN)2, Cd(O3)2, Cd(OH)2, Cd(NO3)2, Cd(C2H3O2)2, CaBr2, CaCl2, Cal2, CaF2, Ca(CN)2, Ca(SCN)2, Ca(O3)2, Ca(OH)2, Ca(NO3)2, Ca(C2H3O2)2, and combinations thereof. In various embodiments of the perovskite single crystal, the additive is BaBr2.
[0078] In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius less than about 255 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius of 250 pm, 251 pm, 252 pm, 253 pm, or 254 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius less than about 220 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius of 215 pm, 216 pm, 217 pm, 218 pm, or 219 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius less than about 190 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius of 165 pm, 166 pm, 167 pm, 167 pm, 169 pm, 170 pm, 171 pm, 172 pm, 173 pm, 174 pm, 175 pm, 176 pm, 178 pm, 179 pm, 180 pm, 181 pm, 182 pm, 183 pm, 184 pm, 185 pm, 186 pm, 188 pm, or 189 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius less than about 160 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius of 150 pm, 151 pm, 152 pm, 153 pm, 154 pm, or 155 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius less than about 120 pm. In various embodiments of the perovskite single crystal, the one or more cations have an ionic radius of 115 pm, 116 pm, 117 pm, 118 pm, or 119 pm.Attorney Docket No. 035052 / 634770
[0079] In various embodiments of the perovskite single crystal, A is selected from the group consisting of methylammonium (MA), formamidinium (FA), Na+, K+, Rb+, and Cs+, and combinations thereof. In various embodiments of the perovskite single crystal, A is selected from the group consisting of MA, FA, and Cs+, and combinations thereof.
[0080] In various embodiments of the perovskite single crystal, X is a combination of Cl' and Br. In various embodiments of the perovskite single crystal, the perovskite single crystal comprises a perovskite composition of formula APbBr3-yCly. In various embodiments of the perovskite single crystal, y is from 0 to about 0.75, from 0 to about 0.50, from 0 to about 0.25, from 0 to about 0.1, from 0 to about 0.05. In various embodiments of the perovskite single crystal, y is 0.01, 0.02, 0.03, 0.04, or 0.05.V. Devices
[0081] In one aspect, the subject matter described herein is directed to a semiconductor device comprising a perovskite single crystal described herein, a metal layer deposited on a first surface of the perovskite single crystal, and a carbon layer deposited on a second surface of the perovskite single crystal, wherein the second surface is approximately parallel to the first surface.
[0082] In various embodiments of the semiconductor device, the metal layer comprises bismuth. In various embodiments of the semiconductor device, the metal layer comprises a thickness of about 50 nm to about 1000 nm.
[0083] In various embodiments of the semiconductor device, the semiconductor device comprises a plurality of electrodes. In various embodiments of the semiconductor device, the plurality of electrodes comprises a plurality of pixel electrodes. In various embodiments of the semiconductor device, the plurality of pixel electrodes is scribed into the metal layer. In various embodiments of the semiconductor device, the semiconductor device comprises a guard-ring scribed into the metal layer. In various embodiments of the semiconductor device, the guard-ring forms a boarder around the plurality of electrodes.
[0084] In various embodiments, the semiconductor device comprises an X-ray detector or a gamma-ray detector.VI. Methods
[0085] In one aspect, the subject matter described herein is directed to a method for producing a perovskite single crystal, comprising: preparing a perovskite precursor solution comprising aAttorney Docket No. 035052 / 634770perovskite material of formula APbX3and an additive of material of formula MZ2or MY in one or more solvents, wherein the perovskite material of formula APbX3is formed from AX and PbX2, wherein A comprises one or more cations having an ionic radius less than about 260 pm, X is selected from the group consisting of Cl’, Br’, I’, and F’, and combinations thereof, M is a divalent metal ion, Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, and acetate, and combinations thereof, and Y is selected from the group consisting of O2’ and CCh2’; and heating the perovskite precursor solution.
[0086] In various embodiments of the method for producing the perovskite single crystal, the method includes agitating the perovskite precursor solution to substantially dissolve the perovskite material and the additive and filtering the perovskite precursor solution prior to heating. In various embodiments of the method for producing the perovskite single crystal, heating the perovskite precursor solution comprises varying the temperature over a time period. In various embodiments, varying the temperature over the time period includes using a hotplate to heat the perovskite precursor solution from room temperature to about 45 °C for about 2 hours. In various embodiments, varying the temperature over the time period also includes using the hotplate to heat the perovskite single crystal at about 38 °C for about 2 hours after the heating of the perovskite single crystal at about 45 °C for about 2 hours. In various embodiments, varying the temperature over the time period further includes using the hotplate to increase the heat of the perovskite single crystal at a rate of about 3 °C per day for 4-5 days after heating of the perovskite single crystal at about 38 °C for about 2 hours.
[0087] In various embodiments of the method for producing the perovskite single crystal, the divalent metal ion has an ionic radius of about 45 pm to about 175 pm. In various embodiments of the method for producing the perovskite single crystal, the divalent metal ion has an ionic radius of about 95 pm to about 145 pm, about 60 pm to about 120 pm, about 45 pm to about 75 pm, about 75 pm to about 150 pm, about 85 pm to about 135 pm, about 90 pm to about 110 pm, about 100 pm to about 155 pm, about 85 pm to about 165 pm, about 50 pm to about 100 pm, about 105 pm to about 150 pm, about 125 pm to about 135 pm, about 115 pm to about 150 pm, about 145 pm to about 165 pm, or about 136 pm to about 175 pm. In various embodiments of the method for producing the perovskite single crystal, the divalent metal ion has an ionic radius of about 109 pm, 110 pm, 111 pm, 112 pm, 113 pm, 114 pm, 115 pm, 116 pm, 117 pm, 118 pm, 119 pm, 120 pm, 121 pm, 122 pm, 123 pm, 124 pm, 125 pm, 126 pm, 127 pm, 128 pm, 129 pm, 130 pm, 131 pm,Attorney Docket No. 035052 / 634770132 pm, 133 pm, 134 pm, 135 pm, 136 pm, 137 pm, 138 pm, 139 pm, 140 pm, 141 pm, 142 pm, 143 pm, 144 pm, 145 pm, 146 pm, 147 pm, 148 pm, or 149 pm.
[0088] In various embodiments of the method for producing the perovskite single crystal, the divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+. In various embodiments of the method for producing the perovskite single crystal, the divalent metal ion is selected from the group consisting of Cd2+, Yb2+, Ba2+, and Sm2+. In various embodiments, the divalent metal ion is Ba2+.
[0089] In various embodiments of the method for producing the perovskite single crystal, the one or more halides include at least one of Cl', Br, I', or F', and the one or more pseudohalides include at least one of CN⁻, SCN⁻, N₃⁻, or (OH)⁻. In various embodiments of the method for producing the perovskite single crystal, Z is Br'. In various embodiments, the additive is BaBr2.
[0090] In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius less than about 255 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius of 250 pm, 251 pm, 252 pm, 253 pm, or 254 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius less than about 220 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius of 215 pm, 216 pm, 217 pm, 218 pm, or 219 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius less than about 190 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius of 165 pm, 166 pm, 167 pm, 167 pm, 169 pm, 170 pm, 171 pm, 172 pm, 173 pm, 174 pm, 175 pm, 176 pm, 178 pm, 179 pm, 180 pm, 181 pm, 182 pm, 183 pm, 184 pm, 185 pm, 186 pm, 188 pm, or 189 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius less than about 160 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius of 150 pm, 151 pm, 152 pm, 153 pm, 154 pm, or 155 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius less than about 120 pm. In various embodiments of the method for producing the perovskite single crystal, the one or more cations have an ionic radius of 115 pm, 116 pm, 117 pm, 118 pm, or 119 pm.Attorney Docket No. 035052 / 634770
[0091] In various embodiments of the method for producing the perovskite single crystal, A is selected from the group consisting of methylammonium (MA), formamidinium (FA), Na+, K+, Rb+, and Cs+, and combinations thereof. In various embodiments of the method for producing the perovskite single crystal, A is selected from the group consisting of MA, FA, and Cs+, and combinations thereof.
[0092] In various embodiments of the method for producing the perovskite single crystal, X is a combination of Cl' and Br. In various embodiments of the method for producing the perovskite single crystal, the perovskite material comprises a perovskite composition of formula APbBrs-yCly. In various embodiments of the method for producing the perovskite single crystal, y is from 0 to about 0.75, from 0 to about 0.50, from 0 to about 0.25, from 0 to about 0.1, from 0 to about 0.05. In various embodiments of the method for producing the perovskite single crystal, y is 0.01, 0.02, 0.03, 0.04, or 0.05.
[0093] In various embodiments of the method for producing the perovskite single crystal, the divalent metal ion is present in the perovskite precursor solution in a first ratio of n moles relative to A in the perovskite precursor solution. In various embodiments of the method for producing the perovskite single crystal, n is from about 0.01 to about 0.08, from about 0.01 to about 0.04, or from about 0.01 to about 0.02.
[0094] In various embodiments of the method for producing the perovskite single crystal, Pb is present in the perovskite precursor solution in a second ratio of k moles relative to A in the perovskite precursor solution. In various embodiments of the method for producing the perovskite single crystal, k is from about 1 to about 0.92.
[0095] In various embodiments of the method for producing the perovskite single crystal, the one of more solvents selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, dimethylformamide, dimethyl sulfoxide, acetonitrile, propionitrile, acetone, ethylacetate, methylene chloride, chloroform, methanol, ethanol, propanol, butanol, isopropanol, ethylene glycol, diethyl ether, glyme, diglyme, propylene carbonate, N-methyl-2-pyrrolidinone, y-Butyrolactone (gamma-butyrolactone), tetrahydrofuran, benzene, toluene, decalin, hexamethylphosphoramide, pyridine, alkylpyridine, pyrrolidine, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, water, carbon disulfide, supercritical carbon dioxide, carbon tetrachloride, 2 -Methoxy ethanol, l-methyl-2-pyrrolidinone, and sulfuryl chloride fluoride. In various embodiments of the method for producing the perovskite single crystal, theAttorney Docket No. 035052 / 634770one of more solvents selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, dimethyl sulfoxide, dimethylformamide, y -butyrolactone, 2-methoxy ethanol, l-methyl-2-pyrrolidinone, toluene, propylene carbonate, and acetonitrile.
[0096] In various embodiments of the method for producing the perovskite single crystal, the one or more solvents comprise a mixed-solvent system. In various embodiments of the method for producing the perovskite single crystal, the mixed-solvent system comprises dimethylformamide:y-butyrolactone in a ratio of approximately 1:1 volume per volume. In other words, in various embodiments of the method for producing the perovskite single crystal, the mixed solvent system comprises dimethylformamide and y-butyrolactone in equal amounts volume per volume. In various embodiments of the method for producing the perovskite single crystal, the mixed-solvent system comprises dimethylformamide:propylene carbonate in a ratio of approximately 2:1 volume per volume. In other words, in various embodiments of the method for producing the perovskite single crystal, the mixed solvent system comprises twice the amount of dimethylformamide as propylene carbonate volume per volume.
[0097] The subject matter described herein includes the following non-limiting embodiments:1. A perovskite precursor solution, comprising:i. a perovskite material of formula APbX3, wherein:A comprises one or more cations having an ionic radius less than about 260 pm; andX is selected from the group consisting of CT, Br, T, and F’, and combinations thereof;ii. an additive material of formula MZ2 or MY, wherein:M is a divalent metal ion;Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, acetate, and combinations thereof;Y is selected from the group consisting of O2-and CO32-; and iii. one or more solvents.2. The perovskite precursor solution of embodiment 1, wherein said divalent metal ion has an ionic radius of about 45 pm to about 175 pm.Attorney Docket No. 035052 / 6347703. The perovskite precursor solution of embodiment 1 or 2, wherein said divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+.4. The perovskite precursor solution of embodiment 1 or 2, wherein said divalent metal ion has an ionic radius of about 136 pm to about 175 pm.5. The perovskite precursor solution of any one of embodiments 1-4, wherein said divalent metal ion is selected from the group consisting of Ba2+, Sm2+, and Nd2+.6. The perovskite precursor solution of any one of embodiments 1-5, wherein said divalent metal ion is Ba2+.7. The perovskite precursor solution of any one of embodiments 1-6, wherein the one or more halides are Cl', Br, T, or F', and wherein the one or more pseudohalides are CN’, SCN', N3', or (OH)'.8. The perovskite precursor solution of any one of embodiments 1-7, wherein Z is Br.9. The perovskite precursor solution of any one of embodiments 1-8, wherein A is selected from the group consisting of methylammonium (MA), formamidinium (FA), and cesium (Cs+), and combinations thereof.10. The perovskite precursor solution of any one of embodiments 1-9, wherein X is a combination of Cl’ and Br.11. The perovskite precursor solution of any one of embodiments 1-10, wherein said perovskite material comprises a perovskite composition of formula APbBr3-yCly, wherein y is from 0 to about 0.75.Attorney Docket No. 035052 / 63477012. The perovskite precursor solution of embodiment 11, wherein y is about 0.03.13. The perovskite precursor solution of any one of embodiments 1-12, wherein said divalent metal ion is present in said perovskite precursor solution in a first ratio of n moles relative to A in said perovskite precursor solution, wherein n is from about 0.01 to about 0.08.14. The perovskite precursor solution of embodiment 13, wherein n is from about 0.01 to about 0.04.15. The perovskite precursor solution of embodiment 13, wherein n is from about 0.01 to about 0.02.16. The perovskite precursor solution of embodiment 13, wherein Pb is present in said perovskite precursor solution in a second ratio of k moles relative to A in said perovskite precursor solution, wherein k is from about 1 to about 0.92.17. The perovskite precursor solution of any one of embodiments 1-16, wherein said one or more solvents are selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, dimethyl sulfoxide, dimethylformamide, y-butyrolactone, 2-methoxyethanol, 1 -methyl -2-pyrrolidinone, toluene, propylene carbonate, and acetonitrile.18. The perovskite precursor solution of any one of embodiments 1-17, wherein said one or more solvents comprises a mixed-solvent system.19. The perovskite precursor solution of embodiment 18, wherein said mixed-solvent system comprises dimethylformamide:y-butyrolactone in a ratio of approximately 1:1 volume per volume or dimethylformamide:propylene carbonate in a ratio of approximately 2:1 volume per volume.Attorney Docket No. 035052 / 63477020. A perovskite single crystal of formula APbX3, wherein:A comprises one or more cations having an ionic radius less than about 260 pm,X is selected from the group consisting of Cl’, Br, I’, and F’, and combinations thereof, andsaid single crystal comprising a plurality of Pb vacancies occupied by a dopant, wherein said dopant comprises a divalent metal ion, and is present in said perovskite single crystal in an amount of about 1 to about 9 mol % relative to Pb in said perovskite single crystal.21. The perovskite single crystal of embodiment 20, wherein said dopant predominately resides in said plurality of Pb vacancies that occur below a surface of said perovskite single crystal.22. The perovskite single crystal of embodiment 20 or 21, wherein said divalent metal ion has an ionic radius of about 45 pm to about 175 pm.23. The perovskite single crystal of any one of embodiments 20-22, wherein said divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+.24. The perovskite single crystal of any one of embodiments 20-22, wherein said divalent metal ion has an ionic radius of about 136 pm to about 175 pm.25. The perovskite single crystal of any one of embodiments 20-24, wherein said divalent metal ion is selected from the group consisting of Ba2+, Sm2+, and Nd2+.26. The perovskite single crystal of any one of embodiments 20-25, wherein said divalent metal ion is Ba2+’.Attorney Docket No. 035052 / 63477027. The perovskite single crystal of any one of embodiments 20-26, wherein X is a combination of Cl' and Br.28. The perovskite single crystal of any one of embodiments 20-27, wherein the perovskite single crystal comprises a perovskite composition of formula APbBr3-yCly, wherein y is from 0 to about 0.75.29. The perovskite single crystal of embodiment 28, wherein y is about 0.03.30. A semiconductor device comprising the perovskite single crystal of any one of embodiments 20-29, a metal layer deposited on a first surface of said perovskite single crystal, and a carbon layer deposited on a second surface of said perovskite single crystal, wherein said second surface is approximately parallel to said first surface.31. The semiconductor device of embodiment 30, wherein said metal layer comprises bismuth.32. The semiconductor device of embodiment 30 or 31, wherein said metal layer comprises a thickness of about 50 nm to about 1000 nm.33. The semiconductor device of any one of embodiments 30-32, further comprising a plurality of electrodes.34. The semiconductor device of embodiment 33, wherein said plurality of electrodes comprises a plurality of pixel electrodes, and wherein said plurality of pixel electrodes are scribed into said metal layer.35. The semiconductor device of embodiment 33 or 34, further comprising:a guard-ring scribed into said metal layer, wherein said guard-ring forms a border around said plurality of electrodes.Attorney Docket No. 035052 / 63477036. The semiconductor device of any one of embodiments 30-35, wherein said semiconductor device comprises an x-ray detector or a gamma-ray detector.37. A method of producing a perovskite single crystal, comprising: preparing a perovskite precursor solution comprising a perovskite material of formula APbX3 and an additive of material of formula MZ2 or MY in one or more solvents, wherein the perovskite material of formula APbX3 is formed from AX and PbX2,wherein,A comprises one or more cations having an ionic radius less than about 260 pm,X is selected from the group consisting of Cl’, Br, I’, and F’, and combinations thereof,M is a divalent metal ion,Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, acetate, and combinations thereof, andY is selected from the group consisting of O2’ and CCh2’; and heating said perovskite precursor solution.38. The method of embodiment 37, further comprising:agitating said perovskite precursor solution to substantially dissolve the perovskite material and the additive; andfiltering said perovskite precursor solution prior to heating.39. The method of embodiment 37 or 38, wherein heating said perovskite precursor solution comprises varying the temperature over a time period.40. The method of any one of embodiments 37-39, wherein said divalent metal ion has an ionic radius of about 45 pm to about 175 pm.Attorney Docket No. 035052 / 63477041. The method of any one of embodiments 37-40, wherein said divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+.42. The method of any one of embodiments 37-40, wherein said divalent metal ion has an ionic radius of about 136 pm to about 175 pm.43. The method of any one of embodiments 37-42, wherein said divalent metal ion is selected from the group consisting of Ba2+, Sm2+, and Nd2+.44. The method of any one of embodiment 37-43, wherein said divalent metal ion is Ba2+'.45. The method of any one of embodiments 37-44, wherein the one or more halides are Cl', Br', T, or F', and wherein the one or more pseudohalides are CN', SCN', Ns', or (OH)'.46. The method of any one of embodiments 37-45, wherein Z is Br'.47. The method of any one of embodiments 37-46, wherein A is selected from the group consisting of methylammonium (MA), formamidinium (FA), and cesium (Cs+), and combinations thereof.48. The method of any one of embodiments 37-47, wherein X is a combination of Cl' and Br'.49. The method of any one of embodiments 37-48, wherein said perovskite material comprises a perovskite composition of formula APbBr3-yCly, wherein y is from 0 to about 0.75.50. The method of embodiment 49, wherein y is about 0.03.Attorney Docket No. 035052 / 63477051. The method of any one of embodiments 37-40, wherein said divalent metal ion is present in said perovskite precursor solution in a first ratio of n moles relative to A in said perovskite precursor solution, wherein n is from about 0.01 to about 0.08.52. The method of embodiment 51, wherein n is from about 0.01 to about 0.04.53. The method of embodiment 51 or 52, wherein n is from about 0.01 to about 0.02.54. The method of any one of embodiments 37-53, wherein Pb is present in said perovskite precursor solution in a second ratio of k moles relative to A in said perovskite precursor solution, wherein k is from about 1 to about 0.92.55. The method of any one of embodiments 37-54, wherein said one or more solvents are selected from the group consisting of dimethyl sulfoxide, dimethylformamide, y-butyrolactone, 2-methoxyethanol, l-methyl-2-pyrrolidinone, propylene carbonate and acetonitrile.56. The method of any one of embodiments 37-55, wherein said one or more solvents comprises a mixed-solvent system.57. The method of any one of embodiments 56, wherein said mixed-solvent system comprises dimethylformamide:y-butyrolactone in a ratio of approximately 1:1 volume per volume or dimethylformamide:propylene carbonate in a ratio of approximately 2:1 volume per volume.EXAMPLESMaterials and Methods
[0098] Formamidinium bromide (FABr), Lead bromide (PbBr2), Barium bromide (BaBr2), Calcium bromide (CaBr2), Cadmium bromide (CdBr2), Strontium bromide (SrBr2), N, N-Dimethylformamide (DMF), and y-Butyrolactone (GBL). For stoichiometrically doped crystals, a 1.4 M precursor solution was prepared by dissolving FABr: PbBr2: BBr2, a stoichiometric ratio ofAttorney Docket No. 035052 / 6347701:l-x:x, in a mixed-solvent system, in which x = 0.01, 0.02, 0.04, or 0.08, B = Ba, Ca, Cd, or Sr, and the mixed-solvent system includes DMF: GBL in a ratio of 1:1 volume per volume (v / v). For non-stoichiometrically doped crystals, a 1.4 M precursor solution was prepared by dissolving FABr: PbBr2: BBr2, a non-stoichiometric ratio of l:l:x, in a mixed-solvent system, in which x = 0.01, 0.02, 0.04, or 0.08, B = Ba, Ca, Cd, or Sr and the mixed-solvent system includes DMF: GBL in a ratio of 1: 1 v / v.
[0099] Following constant stirring at room temperature for about 12 hours, FABr: PbBr2: BBr2 (referred to as salts) substantially dissolved in the mixed-solvent system to form a clear precursor solution. The precursor solution was then filtered using a polytetrafluoroethylene (PTFE) filter with about a 0.2 pm pore size. The filtered precursor solution was transferred to a beaker and placed onto a hotplate at about 45 °C for about 2 hours. After the heating at about 45 °C for about2 hours, several relatively small crystals were formed on the bottom of the beaker. The remaining clear solution was then transferred to several 25 ml beakers for crystal growth. Parafilm, with nine holes form by poking the parafilm with a needle, was placed on top of the 25 ml beakers to reduce the evaporation rate. The 25 ml beakers were then placed onto hotplate at about 38 °C for about 2 hours. After the heating at about 38 °C for about 2 hours, the temperature of the hotplate was increased at a rate of about 3 °C per day. After heating for about 4-5 days, centimeter-sized crystals formed in the 25 ml beakers. In other words, centimeter-sized crystals were grown from the precursor solution after 4-5 days.Device Fabrication
[0100] As-grown crystal surfaces were fine polished, mechanically with 3 M polishing papers (400-8,000 grits). The residue on the polished surface was washed away by toluene. The polished crystals were then dried in a nitrogen flow. A several hundred-nm-thick bismuth layer was deposited on the top surfaces of the crystals by thermal evaporation. Carbon paste was brushed on the bottom surfaces of the crystals. The carbon paste was then dried by placing the crystals onto a hotplate at about 80 °C for about 15 minutes. Laser-scribing was then used to form pixel electrodes in the bismuth layer. The pixel electrodes were connected via a gold wire to an outer electric circuit.Results and DiscussionAttorney Docket No. 035052 / 634770Example 1: Examination of the Inconsistency in Crystal Quality of FAPbBr3 Single Crystals
[0101] In the process of synthesizing a set of FAPbBrs single crystals, inconsistencies in crystal quality (evaluated based on as-fabricated device performance) were observed despite maintaining ostensibly identical synthesis conditions. For example, a set of devices fabricated from the set of FAPbBrs single crystals showed significant variation in X-ray detection performance. Additionally, the champion device (the device with the highest performance among the set of as-fabricated devices) achieved an energy resolution of 1.7% under illumination from a137Cs gammaray source, which is relatively poor compared to commercial CZT-based products. That is, the gamma-ray detection performance of the champion device was poor relative to commercial CZT-based products.
[0102] Upon examination of the process used for synthesizing the set of FAPbBrs single crystals, the origin of the variation in X-ray detection performance was isolated to the PbBn raw material. As inferred from Table 1, utilizing PbBn of low-purity (>98%) resulted in crystal quality that is contingent on the batch of PbB. In other words, the quality of crystals formed using low-purity (>98%) PbBr2 was dependent upon the batch of low-purity (>98%) PbBr2 from which the crystals were formed. It is noted that, while the batch of low-purity (>98%) PbB determined the resulting crystal quality, crystals derived from the same batch of low-purity (>98%) PbB demonstrate consistent quality. That is, crystal quality was substantially the same among crystals formed from the same batch of low-purity (>98%) PbBn. In contrast, when high-purity (>99.9%) PbBn is used, none of the crystal devices yield a gamma ray spectrum, irrespective of the batch. The findings indicated that impurity ions inherent in the raw material impact the quality of the resulting single crystals.
[0103] Tablet below illustrates the device performance comparison between crystals grown using the low-purity PbBr₂ (>98%) and crystals grown using the high-purity PbBn (>99.9%). Three different batches were used for each of the low-purity PbBr2 and the high-purity PbBr?. For example, in Table 1 below, LP-1-1 means low-purity PbBr2, batch 1, crystal number 1. Additionally, in Table 1 below, HP-2-2 means high-purity PbBn, batch 2, crystal number 2. Moreover, in Table 1 below, LP-1 and LP-3 refer to different batches of PbBr2 (>98%) sourced from Sigma-Aldrich, LP-2 refers to a batch of PbBr2 (>98%) sourced from Stream, and HP-1, HP-2, and HP-3 refer to different batches of PbBr2 (>99.9%) sourced from Prochem.Attorney Docket No. 035052 / 634770Example 2: Using Metal Ions Additives to Improve the Crystal Quality (Stoichiometrically Alloying)
[0104] To determine the impact on crystal quality of impurity ions inherent in the raw material used to form the crystals, a systematic study was conducted by deliberately introducing bivalent cations with different ion size. The bivalent cations include Ba2+, Cd2+, Sr2+, and Ca2+, and act as analogs for impurities present in low-purity PbBr₂. Unless otherwise specified, the compositions used in Example 2 are stoichiometric. Additionally, unless otherwise specified, the concentration of the bivalent cations (M2+) used in Example 2 are 2 mol% (e.g., M2+ / (M2++Pb2+) =2%).
[0105] Figures 1A through IF illustrate results associated with Example 2. More specifically, Figure 1A shows a plot of energy resolution for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution. Unless otherwise specified, energy resolution data presented herein was determined from the 662 keV photopeak from a137Cs gamma-ray source. Figure IB shows a plot of charge collection efficiency for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution. Figure 1C shows a plot of Photopeak / Compton peak height (P / C) ratio for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution. Figure ID shows a plot of dark current density for FAPbBr3 single crystal devices prepared without an additive (Pb2+, undoped), or with 2 mol% of Ba2+, Cd2+, Sr2+, or Ca2+added to their respective precursor solution. In other words, Figures 1A through 1D show comparisons of the energy resolution, charge collection efficiency, P / C ratio, and dark current density, respectively, for different ion alloyed crystal device. In Figures 1A through 1D, data points labeled Pb2+represent an undoped FAPbBr₃ single crystal device.Attorney Docket No. 035052 / 634770Figure IE shows a plot of a137Cs spectrum of an undoped FAPbBr3 single crystal device. Figure 1F shows a plot of a137Cs spectrum of a FAPbBr₃ single crystal device prepared with 2 mol% of Ba2+added to its precursor solution. In other words, Figures 1E and 1F show comparison of137Cs spectra between an undoped (pure) FAPbBr₃ crystal device and 2 mol% Ba2+alloyed device, respectively.
[0106] As shown in Figures 1A through ID, the incorporation of larger ions, notably Ba2+, yielded a pronounced improvement in crystal quality relative to the undoped FAPbBr₃ crystal, as evidenced by the improved charge collection efficiency (-100% under 400 V) and improved energy resolution (1.11%) for137Cs gamma-ray spectrum achieved by the Ba2+doped FAPbBr₃ single crystal device. In other words, as shown in Figures 1A and IB, the Ba2+doped FAPbBr₃ single crystal device achieved the lowest energy resolution (1.11%) and the highest charge collection efficiency (~100% under 400 V) among the tested FAPbBr₃ single crystal devices.
[0107] The incorporation of smaller ions exhibited varied results. For example, FAPbBr₃ single crystal devices doped with Ca2+and Cd2+provided improved charge collection efficiency relative to the undoped FAPbBr₃ single crystal device but failed to improve energy resolution. Additionally, Sr2+, which is comparable in size to Pb2+, adversely impacted device performance. For example, as shown in Figures 1A and IB, the highest energy resolution and lowest charge collection efficiency was achieved by the FAPbBr₃ single crystal device doped with Sr2+.
[0108] Figures IE and IF show the137Cs gamma-ray spectrum performance difference between the undoped FAPbBr₃ crystal device and the Ba2+doped crystal device. As illustrated in Figures 1A through IF, the energy resolution, P / C peak height ratio, and charge collection efficiency were improved with Ba2+addition. The results illustrated in Figures 1A through 1F were highly reproducible, even with the use of low-purity PbBr2 (98%). The results presented in Figures 1A through IF indicate that the incorporation of divalent metal ions into FAPbBr₃ single crystals reduces lead vacancies and improves both crystal quality and resultant device performance.
[0109] Figures 2A through 2H also illustrate results associated with Example 2. More specifically, Figures 2A through 2H illustrate the impact of BaBn additive content in precursor solution on device performance. For example, Figure 2A shows plots of precursor solubility curves for FAPbBr₃ precursor solutions prepared with varying amounts of Ba2+. In other words, Figure 2A shows the precursor solubility curve of FAPbBr₃ with different Ba2+alloying content (also referred to herein as doping content). Figure 2B shows plots of unit cell volume and FWHM of theAttorney Docket No. 035052 / 634770(001) XRD peak for FAPbBr3 single crystals prepared with varying amounts of Ba2+added to their respective precursor solution. In other words, Figure 2B shows the unit cell volume changes and FWHM of (001) XRD peak changes with different Ba2+alloying content. Figure 2C shows plots of dark current density for FAPbBr₃ single crystal devices prepared with varying amounts of Ba2+added to their respective precursor solution. In other words, Figure 2C shows the dark current density of FAPbBr₃ crystal device with different Ba2+alloying content. Figures 2D through 2H show plots of137Cs spectra of FABaxPbi-xBr3 single crystal devices prepared with varying amounts of Ba2+added to their respective precursor solution. In other words, Figures 2D through 2H show137Cs spectra of FABaxPb1-xBr₃ crystal device with different Ba2+content.
[0110] As illustrated in Figure 2A, the BaBr2 additives increased the precursor solubility and decreased the crystal growth rate. Single crystals were harvested across a large range of BaBr2 additive ratio from about 1 mol% to about 8 mol%. However, the high-quality crystal growth yield experienced a significant decline when the Ba2+ / (Ba2++Pb2+) ratio surpassed about 2%. As illustrated in Figure 2B, using X-ray diffraction, a lattice volume increase with increased Ba2+content was observed, which confirmed the successful incorporation of Ba2+ions into the perovskite crystals. The formed perovskite crystals were therefore an alloy having a composition of formula FABaxPbi-xBr3. The lattice volume change was linear and then slowly saturated when Ba2+ / (Ba2++Pb2+) ratio reached about 4%. Additionally, Figure 2B shows the change of FWHM of the (001) peak of the perovskite crystals with different Ba2+alloying content. The results illustrated in Figure 2B demonstrate that by adding a suitable amount of Ba2+(e.g., less than about 4 mol%), the FWHM of the (001) peak becomes narrower, indicating enhanced crystal quality. Conversely, a broader FWHM resulting from excessive alloying suggests that increasing the alloying level (e.g., beyond about 4 mol%) may deteriorate the quality of the crystal. As illustrated in Figures 2D through 2H, a device performance improvement was observed when the Ba2+ / (Ba2++Pb2+) ratio increased from 0% to 2%. Further increasing the Ba2+ / (Ba2++Pb2+) ratio beyond about 2% may reduce the device performance. The results shown in Figures 2A through 2H indicate that a ratio of about 2% is suitable for Ba2+in a FAPbBr₃ matrix.
[0111] Figures 3A through 3C further illustrate results associated with Example 2. More specifically, Figures 3A through 3C illustrate the impact of varying the CT content on undoped FAPbBr₃ and on FAPbBr₃ doped with Ba2+. In other words, Figures 3A through 3C illustrate the impact on device performance of BaBr₂ additive content in a mixed halide (FAPbBr3-xClx)Attorney Docket No. 035052 / 634770precursor solution. Figure 3A shows an optical image, under daylight, of FAPbBr₃ single crystals prepared with varying amounts of Cl' added to their respective precursor solution. In other words, Figure 3A shows optical images of as-grown FAPbBr3.xClxcrystals with different Cl’ content under day light. Figure 3B shows a plot of energy resolution for FAPbBr₃ single crystals prepared with varying amounts of CF added to their respective precursor solution. In other words, Figure 3B shows energy resolution of as-fabricated crystals device with different C1‘ content determined from the 662 keV photopeak of137Cs spectra. As illustrated in Figure 3B, devices with 25 mol% Cl⁻ showed no distinguishable137Cs spectra. Figure 3C shows a plot of a137Cs spectrum for a FAPbBr3 single crystal prepared with 1 mol% of CF and 2 mol% of Ba2+added to its precursor solution. In other words, Figure 3C shows the137Cs spectrum of a 1 mol% Cl⁻ and 2 mol% Ba2+co-incorporated crystal device.
[0112] As depicted in Figure 3A, centimeter-scale single crystals were produced by increasing the Cl⁻ content from 0 mol% to about 25 mol%. The observed change in color as the Cl⁻ content is increased from 0 mol% to about 25 mol% corresponds to an increase in the bandgap of the resulting perovskite single crystal, which confirmed the successful incorporation of Cl⁻ into the resulting perovskite single crystal. As shown in Figure 3B, to quantify the performance of devices fabricated using the as-grown single crystals, energy resolution was measured using the 662 keV photopeak of137Cs gamma-ray spectra collected from the devices. Except for samples with 25 mol% of Cl⁻, all compositions displayed in Figure 3B yielded distinguishable spectra. The performance yielded from the device with a concentration of about 1 mol% Cl⁻ was nearly identical to the performance of undoped FAPbBr₃. That is, the device fabricated using a perovskite single crystal formed from a precursor solution with a CF concentration of about 1 mol% yielded an energy resolution of approximately 2%. As illustrated in Figure 3C, a device utilizing perovskite single crystals with about 1 mol% Cl⁻ and about 2 mol% Ba2+achieved137Cs gamma-ray spectra with an energy resolution of about 1.13%. The results illustrated in Figures 3A through 3C indicate that the enhanced crystal properties observed from Ba2+substitution are broadly applicable to a wide range of perovskite compositions.Example 3: Guard Ring to Reduce Surface Leakage Current
[0113] Leakage current observed for devices with Ba2+was relatively large. Example 3 is directed to determining whether the observed leakage current is due to excess doping to the bulk of the perovskites and / or surface leakage current (surface recombination current caused by surfaceAttorney Docket No. 035052 / 634770defects). In other words, Example 3 is directed to determining whether the observed leakage current is due to bulk defects (e.g., from lead vacancies) or surface defects. One method to reduce the impact of surface leakage current is to adopt a guard ring structure. Thus, to determine whether the observed leakage current is due to excess doping or surface leakage current (e.g., to determine which is limiting, bulk defects or surface defects) a guard ring structure was applied to the perovskite single crystal devices using a laser scribing process. For example, laser scribing was used to form a guard ring around one or more pixel electrodes. In some instances, a gap may exist between at least a portion of the guard ring and the pixel electrode(s). Additionally, in some instances, the guard ring may be formed around the perimeter of the pixel electrode(s) (e.g., around each side of the pixel electrode(s)), such that the guard ring forms a boarder around the pixel electrode(s).
[0114] Figure 4A shows a schematic diagram of a perovskite single crystal (PSC) device with a guard-ring based electrode structure. Figure 4B shows a plot of dark current density for a FAPbBr₃ single crystal device prepared with and without a guard ring under varying bias voltages. In other words, Figure 4B shows the dark current density of devices without and with a guard ring under different bias. As illustrated in Figure 4B, the dark current density observed for the FAPbBr₃ single crystal device prepared without the guard ring was three times the dark current density observed for the FAPbBr₃ single crystal device prepared with the guard ring. In other words, a three times reduction in the dark current density was observed for the FAPbBr₃ single crystal device prepared with the guard ring, indicating that the leakage current is substantially due to surface leakage current. In other words, Figure 4B indicates that surface leakage current dominates the total dark current observed in the FAPbBr₃ single crystal devices. Figure 4C shows a plot of a137Cs spectrum of the FAPbBr₃ single crystal device prepared with a guard ring and with 2 mol% of Ba2+added stoichiometrically to its precursor solution. That is, Figure 4C shows the137Cs spectrum of 2% Ba2+doped crystal device with a guard ring. As illustrated in Figure 4C, the energy resolution of the Ba2+doped crystal device was improved considerably, reaching an energy resolution below 1% for the 662 keV photopeak from137Cs gamma-ray source.Example 4: Using Metal Ion Additives to Improve the Crystal Quality (Non-stoichiometric Alloying)
[0115] Br vacancies are known to be one of the dominating defect types in the surface of perovskite single crystals. In some instances, excess BaBr2 may be added to reduce surface BrAttorney Docket No. 035052 / 634770vacancies.10In other words, non-stoichiometric amounts of BaBr2 may be added to perovskite precursor solutions to reduce surface Br vacancies in the resulting single crystals.
[0116] In this context, Figures 5A and 5B illustrate the effects of non-stoichiometric compositions on crystal quality. More specifically, Figures 5A and 5B illustrate the effects of directly adding BaBr₂ into FAPbBr₃ precursor solutions without reducing the amount of PbBr₂. Figure 5A shows plots of energy resolution (ER) and dark current density for FAPbBr3 single crystals prepared with varying amounts of Ba2+stoichiometrically or non-stoichiometrically added to their respective precursor solution. In other words, Figure 5A shows a comparison of the ER under137Cs gamma-ray illumination (e.g., ER of the 662 keV photopeak from a137Cs gamma-ray source, referred to herein as ER under137Cs 662 keV) and the dark current density under 200 V between stoichiometrically Ba2+alloyed FAPbBr₃ and non-stoichiometrically Ba2+alloyed FAPbBr₃ crystal device. As shown in Figure 5A, devices fabricated from non-stoichiometric Ba2+alloyed crystals exhibit substantially reduced leakage currents compared to stoichiometric Ba2+alloyed crystals under the condition of 0 mol% to about 4 mol% Ba2+alloying (e.g., the ratio of BaBr2: PbBr2 ranged from 0 to about 0.04). The ER under137Cs 662 keV for the devices fabricated from non-stoichiometric Ba2+alloyed crystals was also improved relative to the devices fabricated from stoichiometric Ba2+alloyed crystals without applying a guard ring. Figure 5B shows a plot of a137Cs spectrum of a FAPbBr3 single crystal device prepared without a guard ring and with 2 mol% of BaBr2 non-stoichiometrically added to its precursor solution. In other words, Figure 5B shows the137Cs spectrum of the device synthesized from a non-stoichiometric 2 mol% BaBr2: FAPbBr3 precursor solution, in which the device did not have a guard ring. As illustrated in Figure 5B the device synthesized from the non-stoichiometric 2 mol% BaBr2: FAPbBr3 precursor solution yielded a137Cs spectrum with energy resolution of about 0.9% without using guard ring.Example 5: X-ray Detection Performance
[0117] Figures 6A through 6D show non-spectroscopic X-ray detection performance for an undoped FAPbBr₃ single crystal (referred to herein as a control device) and a FAPbBr₃ single crystal device prepared with 2 mol% of Ba2+non-stoichiometrically added to its precursor solution (referred to herein as an optimized device). As shown in Figures 6A through 6D, the non-spectroscopic X-ray detection performance was improved for the optimized device relative to the control device.Attorney Docket No. 035052 / 634770
[0118] For example, Figure 6A shows a plot of response current of the control device under varying X-ray dose rates. In other words, Figure 6A shows the response current of the undoped FAPbBr₃ single crystal device under X-rays with different dose rates. Figure 6C shows a plot of response current of the optimized device under varying X-ray dose rates. In other words, Figure 6C shows the response current of the 2% Ba2+doped FAPbBr₃ single crystal device under X-rays with different dose rates. For Figure 6A and 6C, the response to X-rays from the control device and the optimized device was demonstrated by turning the incident X-rays with a peak energy of 70 keV on and off. The dose rate was tuned by changing the current of the X-ray tube. The current drift was substantially reduced in the optimized device, further indicating the mitigation of surface defects. Figure 6B shows a plot of current density of the control device under varying X-ray dose rates. In other words, Figure 6B shows the X-ray response of the control device at various dose rates. As shown in Figure 6B, a sensitivity of 4.29×103pC Gyair-1cm-2was derived from the slope of the fitting line. Figure 6D shows a plot of current density of the optimized device under varying X-ray dose rates. In other words, Figure 6D shows the X-ray response of the optimized device at various dose rates. As shown in Figure 6D, a sensitivity of 2.1×104pC Gyair-1cm-2is derived from the slope of the fitting line. As shown in Figures 6B and 6D, the X-ray generated current density signal of both the control device and the optimized device have a linear relationship with the X-ray dose rate. A substantially higher sensitivity (2.1×104pC Gyair-1cm-2) was derived for the optimized device relative to the control device. The enhancement of sensitivity observed for the optimized device agrees well with the mobility-lifetime product enhancement of the optimized device, as described in Example 6 below.Example 6: Physical properties of optimized crystal
[0119] The mobility-lifetime (pr) product is known to be a paramount parameter in the realm of semiconductor detectors. For instance, a substantial pr product for a detector is directly correlated with enhanced charge collection efficiency, which is indicative of the overall performance of the detector. To calculate the mobility-lifetime product of Ba2+alloyed FAPbBr₃-based devices, a modified Hecht equation was used as a fitting tool, leveraging different photopeak positions of an241Am photopeak at 59.5 keV under an array of bias conditions. To discern the electron and hole collections, both the position of the241Am source photopeak and the polarity of the applied bias were strategically altered.Attorney Docket No. 035052 / 634770
[0120] Figure 7A shows a schematic diagram (top) of a perovskite solar cell and a plot (bottom) of electron mobility-lifetime product fitting, according to the modified Hecht equation, for channel numbers of the241Am photopeak at 59.5 keV obtained for an optimized device (e.g., a FAPbBr₃ single crystal device prepared with 2 mol% of Ba2+non-stoichiometrically added to its precursor solution) under varying bias voltages. Figure 7B shows a schematic diagram (top) of a perovskite solar cell and a plot (bottom) of hole mobility-lifetime product fitting, according to the modified Hecht equation, for channel numbers of the241Am photopeak at 59.5 keV obtained for the optimized device under varying bias voltages. In other words, Figures 7A and 7B show the electron mobility-lifetime product fitting and the hole mobility-lifetime product fitting, respectively, for channel numbers of the241Am 59.5 keV photopeak under different biases according to the modified Hecht equation. As shown in Figures 7A and 7B, the hole and electron mobility-lifetime products were ascertained to be 1.3×10-2cm2V-1and 1.1×10-2cm2V-1respectively. The hole and electron mobility-lifetime product values derived for the optimized device offer significant insights into the intrinsic properties of the perovskite material and its potential for high-performance gamma-ray detection.Example 7: Device Stability Evaluation
[0121] To assess the robustness of an optimized device (e.g., a FAPbBr₃ single crystal device prepared with 2 mol% of Ba2+non-stoichiometrically added to its precursor solution), the stability of the optimized device was evaluated under relatively challenging operating conditions to, for example, simulate extreme field conditions, including high-bias and extreme temperatures.Figures 8A through 8D highlight an improved stability observed for the optimized device relative to a control device in both scenarios (high-bias and extreme temperatures), which further underscores the capacity of the optimized device to endure prolonged operation in practical applications, including challenging environmental conditions.
[0122] Figure 8A shows a plot of energy resolution (ER) for the optimized device as a function of testing time under high bias. In other words, Figure 8A shows how the ER under137Cs 662 keV of the optimized device varies with testing time under high bias. As shown in Figure 8A, the optimized device displayed relatively good stability under a high bias of 450 V, with its137Cs spectrum performance remaining virtually unaltered across about an 8-hour test duration. Figure 8B shows a plot of ER under57Co for a CZT device, the control device (e.g., an undoped FAPbBr₃ single crystal device), and the optimized device as a function of temperature. In other words, FigureAttorney Docket No. 035052 / 6347708B shows how the ER of the optimized FAPbBr₃-based device, the control FAPbBr₃-based device, and the CZT device using a57Co source varies with temperature. As shown in Figure 8B, the optimized device was relatively resilient under high temperatures, withstanding conditions as high as about 150 °C. This thermal robustness surpasses that of commercial CZT-based products and is also superior to the control device.
[0123] Figures 8C and 8D illustrate the performance of the optimized device at low temperatures. For example, Figure 8C shows a plot of a137Cs spectrum for the optimized device, collected before subjecting the optimized device to an ice bath. Additionally, Figure 8D shows a plot of a137Cs spectrum for the optimized device, collected after subjecting the optimized device to the 3 hour ice bath. In other words, Figures 8C and 8D show the137Cs spectrum of optimized device before and after a 3h ice bath, respectively. Figures 8C and 8D illustrate the capability of the optimized device to operate efficiently at temperatures nearing 0 °C for > 3 hours. Moreover, at the low-temperature condition, the energy resolution of the optimized device exhibited an enhancement relative to the room-temperature condition, reaching an ER value of about 0.87%. In other words, the ER of the optimized device decreased after subjecting the optimized device to the ice bath. The results illustrated in Figures 8A through 8D underscore the potential use of perovskite single crystals doped with Ba2+for diverse applications, and also indicates that perovskite single crystals doped with Ba2+may be utilized in X-ray spectroscopic detection technologies.
[0124] Efforts have been made to ensure accuracy with respect to numbers used (e.g., amounts, temperature, etc.) but some experimental errors and deviations should be accounted for.
[0125] One skilled in the art will recognize many methods and materials similar or equivalent to those described herein, which could be used in the practicing the subject matter described herein. The present disclosure is in no way limited to just the methods and materials described.
[0126] Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this subject matter belongs.
[0127] Throughout this specification and the claims, the words “comprise,” “comprises,” and “comprising” are used in a non-exclusive sense, except where the context requires otherwise. It is understood that embodiments described herein include “consisting of’ and / or “consisting essentially of’ embodiments.Attorney Docket No. 035052 / 634770
[0128] Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit, unless the context clearly dictates otherwise, between the upper and lower limit of the range and any other stated or intervening value in that stated range, is encompassed. The upper and lower limits of these small ranges which may independently be included in the smaller ranges is also encompassed, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included.
[0129] Many modifications and other embodiments of the inventions set forth herein will come to mind to one skilled in the art to which the inventions pertain having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the inventions are not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.REFERENCES1. Spahn, M. X-ray detectors in medical imaging. Nucl. Instrum. Meth. A 731, 57-63 (2013).2. Kozlov, V., Kemell, M., Vehkamaki, M. & Leskela, M. Degradation effects in TIBr single crystals under prolonged bias voltage. Nucl. Instrum. Methods Phys. Res. A 576, 10-14 (2007).3. Baciak, J. E. & He, Z. Comparison of 5 and 10 mm thick HgI2 pixelated y- ray spectrometers. Nucl. Instrum. Methods Phys. Res. A 505, 191-194 (2003).4. Cooper, R. J., Amman, M., Luke, P. N. & Vetter, K. A prototype high purity germanium detector for high resolution gamma-ray spectroscopy at high count rates. Nucl. Instrum. Meth. A 795, 167-173 (2015).5. Wei, H. & Huang, J. Halide lead perovskites for ionizing radiation detection. Nat. Commun. 10, 1066 (2019).6. Wei, H. et al. Dopant compensation in alloyed CH3NH3PbBr3-xClx perovskite single crystals for gamma-ray spectroscopy. Nat. Mater. 16, 826 (2017).7. Yin, W.-J., Shi, T. & Yan, Y. Unusual defect physics in CH3NH3PbI3 perovskite solar cell absorber. Appl. Phys. Lett. 104, 063903 (2014).Attorney Docket No. 035052 / 6347708. Sabino, F. P., Alex Z., and Gustavo M. D. Intrinsic doping limitations in inorganic lead halide perovskites. Materials Horizons 9, 791-803(2022).9. Ni, Z., Zhao, L., Shi, Z, Dong, Y., Beard, M. C., Huang, J. Under review (2023).10. Zhao, L., Shi, Z., Zhou, Y., Wang, X., Xian, Y., Dong, Y., Reid, O., Ni, Z., Beard, M. C., Yan, F. and Huang, J. Nat. Photonics Accepted (2023).11. Wang, X. et al. Perovskite Solution Aging: What Happened and How to Inhibit? Chem 6, 1369-1378 (2020).12. Keeble, D. J., Wiktor, J., Pathak, S. K., Philips, L. J., Dickmann, M., Durose, K., Snaith, H. J. and Egger, W. Nat. Commun., 12, 5566(2021).
Claims
Attorney Docket No. 035052 / 634770CLAIMSWhat is claimed is:
1. A perovskite precursor solution, comprising:i. a perovskite material of formula APbX3, wherein:A comprises one or more cations having an ionic radius less than about 260 pm; andX is selected from the group consisting of Cl’, Br, I’, and F’, and combinations thereof;ii. an additive material of formula MZ2 or MY, wherein:M is a divalent metal ion;Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, acetate, and combinations thereof;Y is selected from the group consisting of O2' and CCL2’; andiii. one or more solvents.
2. The perovskite precursor solution of claim 1, wherein said divalent metal ion has an ionic radius of about 45 pm to about 175 pm.
3. The perovskite precursor solution of claim 1, wherein said divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, EU2+, Tm2+, Dy2+, and Sr2+.
4. The perovskite precursor solution of claim 1, wherein said divalent metal ion has an ionic radius of about 136 pm to about 175 pm.
5. The perovskite precursor solution of claim 1, wherein said divalent metal ion is selected from the group consisting of Ba2+, Sm2+, and Nd2+.
6. The perovskite precursor solution of claim 1, wherein said divalent metal ion is Ba2+.Attorney Docket No. 035052 / 6347707. The perovskite precursor solution of claim 1, wherein the one or more halides are Cl’, Br', T, or F', and wherein the one or more pseudohalides are CN', SCN', Ns', or (OH)'.
8. The perovskite precursor solution of claim 1, wherein Z is Br'.
9. The perovskite precursor solution of claim 1, wherein A is selected from the group consisting of methyl ammonium (MA), formamidinium (FA), and cesium (Cs+), and combinations thereof.
10. The perovskite precursor solution of claim 1, wherein X is a combination of Cl' and Br'11. The perovskite precursor solution of claim 1, wherein said perovskite material comprises a perovskite composition of formula APbBr3-yCly, wherein y is from 0 to about 0.75.
12. The perovskite precursor solution of claim 11, wherein y is about 0.03.
13. The perovskite precursor solution of claim 1, wherein said divalent metal ion is present in said perovskite precursor solution in a first ratio of n moles relative to A in said perovskite precursor solution, wherein n is from about 0.01 to about 0.08.
14. The perovskite precursor solution of claim 13, wherein n is from about 0.01 to about 0.04.
15. The perovskite precursor solution of claim 13, wherein n is from about 0.01 to about 0.02.
16. The perovskite precursor solution of claim 13, wherein Pb is present in said perovskite precursor solution in a second ratio of k moles relative to A in said perovskite precursor solution, wherein k is from about 1 to about 0.92.Attorney Docket No. 035052 / 63477017. The perovskite precursor solution of any one of claims 1-16, wherein said one or more solvents are selected from the group consisting of hydrofluoric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, dimethyl sulfoxide, dimethylformamide, y -butyrolactone, 2-methoxy ethanol, l-methyl-2-pyrrolidinone, toluene, propylene carbonate, and acetonitrile.
18. The perovskite precursor solution of any one of claims 1-17, wherein said one or more solvents comprises a mixed-solvent system.
19. The perovskite precursor solution of claim 18, wherein said mixed-solvent system comprises dimethylformamide:y-butyrolactone in a ratio of approximately 1: 1 volume per volume or dimethylformamide:propylene carbonate in a ratio of approximately 2: 1 volume per volume.
20. A perovskite single crystal of formula APbX3, wherein:A comprises one or more cations having an ionic radius less than about 260 pm,X is selected from the group consisting of CT, Br, T, and F’, and combinations thereof, and said single crystal comprising a plurality of Pb vacancies occupied by a dopant, wherein said dopant comprises a divalent metal ion, and is present in said perovskite single crystal in an amount of about 1 to about 9 mol % relative to Pb in said perovskite single crystal.
21. The perovskite single crystal of claim 20, wherein said dopant predominately resides in said plurality of Pb vacancies that occur below a surface of said perovskite single crystal.
22. The perovskite single crystal of claim 20, wherein said divalent metal ion has an ionic radius of about 45 pm to about 175 pm.
23. The perovskite single crystal of claim 20, wherein said divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, EU2+, Tm2+, Dy2+, and Sr2+.
24. The perovskite single crystal of claim 20, wherein said divalent metal ion has an ionic radius of about 136 pm to about 175 pm.Attorney Docket No. 035052 / 63477025. The perovskite single crystal of claim 20, wherein said divalent metal ion is selected from the group consisting of Ba2+, Sm2+, and Nd2+.
26. The perovskite single crystal of claim 20, wherein said divalent metal ion is Ba2+'.
27. The perovskite single crystal of claim 20, wherein X is a combination of CT and Br.
28. The perovskite single crystal of claim 20, wherein the perovskite single crystal comprises a perovskite composition of formula APbBr3-yCly, wherein y is from 0 to about 0.75.
29. The perovskite single crystal of claim 28, wherein y is about 0.03.
30. A semiconductor device comprising the perovskite single crystal of any one of claims 20-29, a metal layer deposited on a first surface of said perovskite single crystal, and a carbon layer deposited on a second surface of said perovskite single crystal, wherein said second surface is approximately parallel to said first surface.
31. The semiconductor device of claim 30, wherein said metal layer comprises bismuth.
32. The semiconductor device of claim 30 or 31, wherein said metal layer comprises a thickness of about 50 nm to about 1000 nm.
33. The semiconductor device of any one of claims 30-32, further comprising a plurality of electrodes.
34. The semiconductor device of claim 33, wherein said plurality of electrodes comprises a plurality of pixel electrodes, and wherein said plurality of pixel electrodes are scribed into said metal layer.
35. The semiconductor device of claim 33 or 34, further comprising:Attorney Docket No. 035052 / 634770a guard-ring scribed into said metal layer, wherein said guard-ring forms a border around said plurality of electrodes.
36. The semiconductor device of any one of claims 30-35, wherein said semiconductor device comprises an x-ray detector or a gamma-ray detector.
37. A method of producing a perovskite single crystal, comprising:preparing a perovskite precursor solution comprising a perovskite material of formula APbX3and an additive of material of formula MZ2or MY in one or more solvents, wherein the perovskite material of formula APbX3is formed from AX and PbX2,wherein,A comprises one or more cations having an ionic radius less than about 260 pm,X is selected from the group consisting of Cl', Br, I', and F’, and combinations thereof,M is a divalent metal ion,Z is selected from the group consisting of one or more halides, one or more pseudohalides, nitrate, acetate, and combinations thereof, andY is selected from the group consisting of O2−and CO32−; andheating said perovskite precursor solution.
38. The method of claim 37, further comprising:agitating said perovskite precursor solution to substantially dissolve the perovskite material and the additive; andfiltering said perovskite precursor solution prior to heating.
39. The method of claim 37 or 38, wherein heating said perovskite precursor solution comprises varying the temperature over a time period.
40. The method of claim 37, wherein said divalent metal ion has an ionic radius of about 45 pm to about 175 pm.Attorney Docket No. 035052 / 63477041. The method of claim 37, wherein said divalent metal ion is selected from the group consisting of Be2+, Mg2+, Ti2+, V2+, Mn2+, Zn2+, Ge2+, Cd2+, Ba2+, Yb2+, Sm2+, Ca2+, Nd2+, Eu2+, Tm2+, Dy2+, and Sr2+.
42. The method of claim 37, wherein said divalent metal ion has an ionic radius of about 136 pm to about 175 pm.
43. The method of claim 37, wherein said divalent metal ion is selected from the group consisting of Ba2+, Sm2+, and Nd2+.
44. The method of claim 37, wherein said divalent metal ion is Ba2+’.
45. The method of claim 37, wherein the one or more halides are CT, Br’, T, or F’, and wherein the one or more pseudohalides are CN’, SCN’, Ns’, or (OH)’.
46. The method of claim 37, wherein Z is Br’.
47. The method of claim 37, wherein A is selected from the group consisting of methylammonium (MA), formamidinium (FA), and cesium (Cs+), and combinations thereof.
48. The method of claim 37, wherein X is a combination of CT and Br’.
49. The method of claim 37, wherein said perovskite material comprises a perovskite composition of formula APbBr3-yCly, wherein y is from 0 to about 0.75.
50. The method of claim 49, wherein y is about 0.03.
51. The method of claim 37, wherein said divalent metal ion is present in said perovskite precursor solution in a first ratio of n moles relative to A in said perovskite precursor solution, wherein n is from about 0.01 to about 0.08.Attorney Docket No. 035052 / 63477052. The method of claim 51, wherein n is from about 0.01 to about 0.04.
53. The method of claim 51, wherein n is from about 0.01 to about 0.02.
54. The method of claim 37, wherein Pb is present in said perovskite precursor solution in a second ratio of k moles relative to A in said perovskite precursor solution, wherein k is from about 1 to about 0.92.
55. The method of any one of claims 37-54, wherein said one or more solvents are selected from the group consisting of dimethyl sulfoxide, dimethylformamide, -butyrolactone, 2-methoxy ethanol, l-methyl-2-pyrrolidinone, propylene carbonate and acetonitrile.
56. The method of any one of claims 37-55, wherein said one or more solvents comprises a mixed-solvent system.
57. The method of any one of claims 56, wherein said mixed-solvent system comprises dimethylformamide:y-butyrolactone in a ratio of approximately 1:1 volume per volume or dimethylformamide:propylene carbonate in a ratio of approximately 2:1 volume per volume.
